Utama › Kanser Paru-paru
Kajian klinikal Kanser Paru-paru sedang mengambil peserta di AS
348 kajian untuk Kanser Paru-paru sedang mengambil peserta di lokasi seluruh Amerika Syarikat.
Bandar dengan paling banyak kajian
- Houston, TX78 kajian
- Boston, MA62 kajian
- New York City, NY60 kajian
- Los Angeles, CA45 kajian
- Washington, DC41 kajian
- Arlington, VA41 kajian
- Chicago, IL41 kajian
- Nashville, TN40 kajian
- Baltimore, MD40 kajian
- St. Louis, MO39 kajian
- Columbus, OH37 kajian
- Philadelphia, PA36 kajian
- Seattle, WA33 kajian
- Durham, NC32 kajian
- Atlanta, GA29 kajian
- Tampa, FL29 kajian
- Dallas, TX27 kajian
- Cleveland, OH26 kajian
- San Antonio, TX26 kajian
- Portland, OR26 kajian
- Baldwin Park, CA24 kajian
- San Francisco, CA23 kajian
- San Diego, CA23 kajian
- Pittsburgh, PA23 kajian
- Ann Arbor, MI23 kajian
- Edison, NJ23 kajian
- New Haven, CT22 kajian
- Sacramento, CA22 kajian
- Queens, NY22 kajian
- Milwaukee, WI21 kajian
- Salt Lake City, UT21 kajian
- Orlando, FL21 kajian
- Minneapolis, MN20 kajian
- Detroit, MI20 kajian
- Rochester, MN20 kajian
- Miami, FL20 kajian
- Aurora, CO19 kajian
- Kansas City, MO19 kajian
- Oklahoma City, OK19 kajian
- Evanston, IL19 kajian
Mengikut negeri
- Alabama16 kajian
- Alaska7 kajian
- Arizona34 kajian
- Arkansas19 kajian
- California112 kajian
- Colorado38 kajian
- Connecticut30 kajian
- Delaware11 kajian
- Florida76 kajian
- Georgia40 kajian
- Hawaii8 kajian
- Idaho11 kajian
- Illinois62 kajian
- Indiana25 kajian
- Iowa19 kajian
- Kansas21 kajian
- Kentucky26 kajian
- Louisiana16 kajian
- Maine12 kajian
- Maryland56 kajian
- Massachusetts75 kajian
- Michigan44 kajian
- Minnesota42 kajian
- Mississippi14 kajian
- Missouri44 kajian
- Montana14 kajian
- Nebraska19 kajian
- Nevada11 kajian
- New Hampshire12 kajian
- New Jersey42 kajian
- New Mexico15 kajian
- New York93 kajian
- North Carolina50 kajian
- North Dakota15 kajian
- Ohio68 kajian
- Oklahoma20 kajian
- Oregon31 kajian
- Pennsylvania57 kajian
- Rhode Island6 kajian
- South Carolina19 kajian
- South Dakota15 kajian
- Tennessee58 kajian
- Texas101 kajian
- Utah25 kajian
- Vermont7 kajian
- Virginia58 kajian
- Washington43 kajian
- West Virginia11 kajian
- Wilayah Columbia27 kajian
- Wisconsin31 kajian
Kajian yang dikemas kini baru-baru ini
Teks kajian rasmi (Bahasa Inggeris)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT04267848Evaluation for NCI Surgery Branch Clinical Research Protocols
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT00001823Prospective Multiomic Analysis in Small-Cell Lung Cancer
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07795411Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
Mengambil pesertaKajian pemerhatian
Umur 2 hingga 120 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT00242723Adding Certolizumab to Chemotherapy + Nivolumab in People Who Have Lung Cancer That Can Be Treated With Surgery
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT04991025Smoking Cessation CM for Veterans With or at Risk for Cancer
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06432985The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Mengambil pesertaFasa 1/2
Umur 12 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT04585750Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Mengambil pesertaKajian pemerhatian
Umur 2 hingga 100 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT01950572Distance-Based Exercise to Preserve Function and Prevent Disability
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07059884Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
Mengambil pesertaFasa 1
Umur 18 hingga 120 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06885697Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06780098Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 40 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05334069Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
Mengambil pesertaKajian pemerhatian
Umur 3 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT01441089Cemiplimab and Fianlimab Before Surgery for the Treatment of Stage IB-IIIB Non-Small Cell Lung Cancer
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06918132A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07286149A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06172478Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Mengambil pesertaFasa 3
Umur 70 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06096844Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT04181060Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06625775Empathic Communication Skills (ECS) Training
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 18 hingga 100 · Semua jantina · Dikemas kini 1 Okt 2026 · NCT05456841Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06498635The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07285044Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT06765109Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT06881784DK222 Study at Hopkins
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07140315Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.